San Francisco, 18 March, Nasal Drug Delivery Technology Market Analysis
Report By Therapeutic Application (Asthma, Rhinitis), By Dosage Form (Powder,
Gel, Spray, Drops), By Container Type, And Segment Forecasts, 2019 – 2025.
The global nasal drug delivery systems market size
is expected to reach USD 67.99 billion by 2025 expanding at 6.5% CAGR,
according to a new report by Grand View Research, Inc. Rising awareness about
nasal products is one of the major factors driving the market. Growing
geriatric population is also expected to have positive impact on the market.
According to the United Nations Department of Economic and Social Affairs, the
global geriatric population (60 years and above), was around 962 million in
2017. The number is expected to grow, particularly in Latin America with 71%
rise in population aged 60 and over, followed by Asia (66%), Africa (64%),
North America (41%), and Europe (23%).
Moreover, ongoing product
development and their expected commercialization will propel market growth over
the forecast period. For instance, In April 2018, Dr. Reddy’s Laboratories,
along with its subsidiary Promius Pharma, LLC, announced filing of their New
Drug Application (NDA) for DFN-02, for the treatment of migraine. Increasing
adoption of self-administration practices and focus on other alternative routes
of drug delivery, such as nasal drug delivery, also offer growth opportunities
for the market. Some of the key companies in the industry are AstraZeneca PLC;
OptiNose, Inc.; Pfizer, Inc.; Becton, Dickinson and Company; Promius Pharma
LLC; B.F. Ascher & Company, Inc.; and Cadila Pharmaceuticals Ltd.
Access Full Research
Report On Nasal Drug Delivery Technology Market Analysis:
Further key findings from the study suggest:
·
Nasal sprays led the dosage
type segment in 2017 due to increased prevalence of asthma and other infectious
diseases
·
On the other hand, nasal drops
segment witnessed the fastest growth in 2017 owing to availability of
cost-effective products with better efficacy
·
Non-pressurized containers
segment led the market in 2017 due to continous development in nasal powders
and gel products
·
Asthma was the dominant
therapeutic application segment in 2017 and is estimated to be the
fastest-growing segment with a CAGR of 7.0% during the forecast years due to
increasing disease prevalence
·
Geographically, North America
held the largest share in 2017. Asia Pacific is estimated to witness the
fastest CAGR of 7.5% due to presence of key companies, such as Cipla Inc.
·
Some of the leading companies
in the global nasal drug delivery technology market are GlaxoSmithKline PLC;
AstraZeneca PLC; Pfizer, Inc.; OptiNose, Inc.; Becton, Dickinson and Company;
Promius Pharma, LLC; Cadila Pharmaceuticals Ltd.; B.F. Ascher & Company,
Inc.; PendoPharm, Inc.; Douglas Pharmaceuticals Ltd.; ENT Technologies Pty.
Ltd.; and NAVEH Pharma Ltd.
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the
global nasal drug systems market on the basis of dosage forms, container type,
therapeutic application, and region:
Nasal Drug Delivery Systems Dosage
Forms Outlook (Revenue, USD Billion, 2014 - 2025)
·
Spray
·
Drops
·
Gel
·
Powder
Nasal Drug Delivery Systems Container
Type Outlook (Revenue, USD Billion, 2014 - 2025)
·
Pressurized Container
·
Non-pressurized Container
Nasal Drug Delivery Systems Therapeutic
Application Outlook (Revenue, USD Billion, 2014 - 2025)
·
Nasal Congestion
·
Rhinitis
·
Asthma
·
Others
Nasal Drug Delivery Systems Regional
Outlook (Revenue, USD Billion, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
U.K.
·
Asia Pacific
o
Japan
o
China
o
India
·
Latin America
o
Brazil
o
Mexico
·
Middle East & Africa
o
South Africa
Browse Press
Release of this Report:
www.grandviewresearch.com/press-release/global-nasal-drug-delivery-technology-system-market
www.grandviewresearch.com/press-release/global-nasal-drug-delivery-technology-system-market
About Grand View
Research
Grand View
Research provides syndicated as well as customized research reports and
consulting services on 46 industries across 25 major countries worldwide. This
U.S.-based market research and consulting company is registered in California
and headquartered in San Francisco. Comprising over 425 analysts and
consultants, the company adds 1200+ market research reports to its extensive
database each year. Supported by an interactive market intelligence platform,
the team at Grand View Research guides Fortune 500 companies and prominent
academic institutes in comprehending the global and regional business
environment and carefully identifying future opportunities.
For more
information: www.grandviewresearch.com/
No comments:
Post a Comment